REZOLUTE, INC. Cash
REZOLUTE, INC. (RZLT) had Cash of $13.25 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2023-05-11
- 2023-03-31: Cash $13.25M.
- 2022-06-30: Cash $150.41M.
- 2019-03-31: Cash $15.34M.
- 2018-12-31: Cash $258.19K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2023-03-31 | $13.25M 10-Q · filed 2023-05-11 | |
| 2022-06-30 | $150.41M 10-Q · filed 2023-05-11 | |
| 2019-03-31 | $15.34M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $258.19K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $400.87K 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $1.65M 10-Q · filed 2019-05-10 | |
| 2018-03-31 | $78.12K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $868.07K 10-Q · filed 2019-02-14 | |
| 2017-09-30 | $4.02M 10-Q · filed 2018-12-14 | |
| 2017-06-30 | $4.49M 10-Q · filed 2019-05-10 | |
| 2017-03-31 | $4.44M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $3.57M 10-Q · filed 2018-02-14 | |
| 2016-09-30 | $3.37M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $4.06M 10-K · filed 2018-10-15 | |
| 2016-03-31 | $1.75M 10-Q · filed 2017-05-15 | |
| 2015-12-31 | $1.71M 10-Q · filed 2017-02-02 | $1.71M 10-Q · filed 2016-02-16 |
| 2015-09-30 | $2.35M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $5.28M 10-K · filed 2017-09-22 | |
| 2015-03-31 | $8.22M 10-Q · filed 2016-05-16 | |
| 2014-12-31 | $8.59M 10-Q · filed 2016-02-16 | |
| 2014-09-30 | $4.30M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $5.93M 10-K · filed 2016-09-28 | |
| 2014-03-31 | $5.64M 10-Q · filed 2015-05-15 | |
| 2013-12-31 | $1.14M 10-Q · filed 2015-02-17 | |
| 2013-09-30 | $744.00 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $527.00 10-K · filed 2015-09-28 | |
| 2013-03-31 | $394.11K 10-Q · filed 2014-05-14 | |
| 2012-12-31 | $328.30K 10-Q · filed 2014-02-13 | |
| 2012-09-30 | $291.68K 10-Q · filed 2013-11-12 | $480.00 10-Q · filed 2012-11-19 |
| 2012-06-30 | $25.88K 10-K · filed 2014-09-30 | $5.13K 10-K/A · filed 2012-11-09 |
| 2012-03-31 | $55.89K 10-Q · filed 2013-05-15 | $6.94K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $646.00 10-K · filed 2013-09-11 | $15.85K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $23.48K 10-Q · filed 2012-11-19 | |
| 2011-07-25 | $0.00 10-K/A · filed 2012-11-09 | |
| 2011-06-30 | $0.00 10-Q · filed 2013-05-15 | $37.03K 10-Q · filed 2011-11-14 |
| 2011-03-31 | $40.55K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $478.00 10-K · filed 2013-09-11 | $40.55K 10-Q · filed 2012-02-14 |
| 2010-09-30 | $3.00K 10-Q/A · filed 2011-12-13 | |
| 2010-07-25 | $0.00 10-K/A · filed 2012-11-09 | |
| 2010-03-23 | $0.00 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |